Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Herpes Zoster 1Crohn Disease 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Infliximab 3Certolizumab Pegol 3golimumab 1Vaccines 1Sutures 1Surgical Instruments 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Pneumococcal Vaccines 1Photoplethysmography 1Papillomavirus Vaccines 1Methoxsalen 1MEDI2070 1Lysine Acetyltransferase 5 1Laparoscopy 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Herpes Zoster Vaccine 1Fish Oils 1Calcium Dobesilate 1Calcitriol 1CT-P13 1Bupivacaine 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Crohn Disease × Herpes Zoster Vaccine × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡